Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease (STARLIGHT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05417126 |
|
Recruitment Status :
Completed
First Posted : June 14, 2022
Last Update Posted : November 9, 2023
|
Sponsor:
Nanoscope Therapeutics Inc.
Information provided by (Responsible Party):
Nanoscope Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 2, 2023 |
| Actual Study Completion Date : | September 28, 2023 |